Skip to content

Construction of human-derived neuralized skin organoid model

Construction of human-derived neuralized skin organoid model

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600121376
Enrollment
Unknown
Registered
2026-03-30
Start date
2026-04-30
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Observation group:None

Sponsors

Hangzhou Third People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. 18-55 years of age, scheduled for elective surgery (e.g. plastic/cosmetic surgery); 2. Conscious and fully capable of civil conduct, able to understand the research content and voluntarily sign a written informed consent form. 3. Based on routine hospital examinations prior to surgery, there is no active systemic severe infection. 4. The skin appearance in the surgical area is generally normal, with no signs of acute suppurative infection, severe eczema, or extensive skin ulcers. 5. Consent to the use of discarded skin tissue from their surgery for this study, and consent to its use in in vitro experimental research after de-identification.

Exclusion criteria

Exclusion criteria: 1.Individuals who are unable to fully comprehend research information, or who have mental or cognitive impairments that prevent them from expressing their true wishes. 2.The surgical site exhibits significant acute suppurative infection, severe skin inflammation, malignant tumors, or suspected malignant lesions. 3.Patients with a history of severe hemorrhagic disorders or significant coagulation abnormalities requiring modification of surgical approach or resection extent. 4.Patients with severe systemic diseases (such as decompensated cardiac, hepatic, or renal insufficiency) identified during preoperative assessment, resulting in significantly higher surgical risks than the general population. 5.Individuals known to have HIV infection or other highly infectious diseases, whose tissue is not clinically recommended for inclusion in standard laboratory procedures. 6.Individuals unwilling to participate in this study or who refuse to sign the informed consent form; 7.Other circumstances deemed unsuitable for participation in this study;

Design outcomes

Primary

MeasureTime frame
Keratinocyte markers K14/K10;Fibroblast marker vimentin;

Countries

China

Contacts

Public ContactZhang Zuyong

Hangzhou Third People's Hospital

zzynwk@126.com+86 571 8782 7507

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026